Table 1: Demographics of all 1924 patients in study.

FeatureMeanRange

Age (years)52(15–97)
BMI (Kg/m2)29(14–74)
Parity (#)1(0–9)
Duration of surgery (minutes)121(24–556)
Uterine weight (Kg)216(14–3131)
Pelvic nodes (#)23(0–61)
Inframesenteric nodes (#)7(0–38)
Infrarenal nodes (#)7(0–37)
Transfusions (#PRBC)0(0–5)
Hospital stay (days)1(1–13)

Preoperative diagnosis(%)

Pelvic mass41521.6%
Leiomyoma40020.8%
Endometrial carcinoma35518.5%
Pelvic pain1266.5%
BrCa+/family history1085.6%
Endometrial hyperplasia1005.2%
Transgender944.9%
Adenomyosis864.5%
Prolapse683.5%
Cervical carcinoma492.5%
Ovarian/tubal carcinoma351.8%
Cervical dysplasia311.6%
Menorrhagia251.3%
Stress incontinence150.8%
Uterine stromal/other130.7%
Menstrual migraines/PCOS30.2%
PID10.1%

Procedure%

TLH-BSO172390%
Appendectomy110357%
Any lymphadenectomy20511%
McCall’s colposuspension1498%
Adhesiolysis1347%
Endometriosis resection834%
Burch774%
RLH-BSO764%
TLH684%
TLH-BS483%
TOT261%
Ureterolysis211%
Herniorrhaphy131%
Posterior repair 111%
Minilaparotomy70%
Cholecystectomy60%
Converted50%
Tumor debulking50%
RLH-BS40%
Converted 30%
Episiotomy20%

Postoperative diagnosis%

Leiomyoma61532.0%
Endometrial carcinoma36819.1%
Benign ovarian neoplasia36318.9%
Adenomyosis1749.0%
Endometriosis1276.6%
Ovarian/tubal carcinoma985.1%
Endometrial hyperplasia713.7%
Cervical carcinoma492.5%
Cervical dysplasia261.4%
Adhesions150.8%
Uterine stromal/other90.5%
Metastatic cancer70.4%
PID20.1%